Steven D. Ertel, EVP & Chief Operating Officer at ACCELERON PHARMA INC (XLRN), sold 2,500 shares at $27.61 ($69K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Open-market sale of $69k XLRN by EVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.92 | 600 | $16K | 23.5% |
| 2 | $27.61 | 1,900 | $52K | 76.5% |
| Total | $27.44 avg | 2,500 | $69K | 100% |
| Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |
| XLRN | SELL | 2015-07-17 | $63K | — | Filing → |